Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice

BACKGROUND: Diabetes accelerates atherosclerosis through undefined molecular mechanisms. Hyperglycemia induces formation of advanced glycation end product (AGE)-modified low-density lipoprotein (LDL). Anti-AGE-LDL autoantibodies favor atherosclerosis (AS) progression in humans, while anti oxidized L...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cardiovasc Diabetol
Glavni autori: Zhu, Lin, He, Zhiqing, Wu, Feng, Ding, Ru, Jiang, Qixia, Zhang, Jiayou, Fan, Min, Wang, Xing, Eva, Bengtsson, Jan, Nilsson, Liang, Chun, Wu, Zonggui
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234834/
https://ncbi.nlm.nih.gov/pubmed/25391642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0151-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items